We demonstrate that clofibrate suppressed the growth of breast cancer cells in conjunction with the reduction of inflammatory (COX-2/5LO), lipogenic pathways, and a significant induction of genes involved in fatty acid oxidation. This evidence concerns the gene PTGS2 and breast cancer.